Hillary Clinton All Bark, No Bite with Biotech Tweet

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/12/2026

1. ORCL
2. SPY
3. SPCX
4. USO
5. CHWY
6. NAVN
7. ADBE
8. CRWV
9. CME
10. HUMA

Go back to Hillary Clinton All Bark, No Bite with Biotech Tweet

Market Reaction to Clinton Proposals Seen as 'Premature' and 'Overdone' - TD Securities (VRX)

September 23, 2015 11:42 AM EDT

TD Securities maintained a Buy rating on Valeant Pharmaceuticals (NYSE: VRX) with a price target of $300. Analyst Lennox Gibbs called the market's reaction to proposals from presidential candidate Hillary Clinton premature and overdone.

Gibbs views plans to authorize Medicare to negotiate prices with drug manufacturers as the most noteworthy of Clinton's proposals, and he pointed out that Valeant derives an estimated 1520% of its revenues from Medicare.

"Drug stocks are down 3% since... More

Hillary Clinton Tweet Doesn't Change Bullish View on Valeant Pharmaceuticals (VRX), BMO Capital Says

September 21, 2015 1:57 PM EDT

BMO Capital analyst Alex Arfaei weighed in on Valeant Pharmaceuticals (NYSE: VRX) which is down 6% in response to a Tweet from Hillary Clinton referring to this article in the... More

UPDATE: Biotech Bounces Off Lows (IBB)

September 21, 2015 1:19 PM EDT

(Updated - September 21, 2015 1:29 PM EDT)

Biotech stocks bounced off lows Monday afternoon, paring declines that were largely driven by fears of increased government regulation of drug pricing. The source of concern was a tweet by presidential candidate Hillary Clinton... More